Alx Oncology Holdings (ALXO) financials · $207.2M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Alx Oncology Holdings (ALXO) $207.2M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$104.0M | -$142.5M |
| Net Income | -$101.7M | -$134.8M |
| EPS (Diluted) | -$1.90 | -$2.58 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $59.0M | $147.8M |
| Current Assets | $50.7M | $134.4M |
| Cash & Equivalents | $16.4M | $17.6M |
| PP&E | $1.20M | $2.90M |
| Total Liabilities | $33.1M | $34.2M |
| Current Liabilities | $24.6M | $18.5M |
| Short-term Debt | $5.22M | $435.0K |
| Long-term Debt | $4.53M | $9.47M |
| Total Debt | $9.75M† | $9.90M† |
| Shareholders' Equity | $26.0M | $113.6M |
| Retained Earnings | -$722.8M | -$621.1M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$84.1M | -$121.9M |
| CapEx | $212.0K | $447.0K |
| Investing Cash Flow | $82.6M | $86.3M |
| Financing Cash Flow | $362.0K | $30.8M |
| Free Cash Flow | -$84.4M | -$122.4M |
FAQ
What is ALXO P/E and revenue?
Alx Oncology Holdings (ALXO) $207.2M cap.
What is ALXO revenue?
ALXO income-statement cache has no revenue figure yet.
Is ALXO profitable?
Alx Oncology Holdings last cached net income is -$101.7M (FY2025).
What are ALXO total assets?
Alx Oncology Holdings last cached total assets are $59.0M (FY2025).
What is ALXO free cash flow?
Alx Oncology Holdings last cached free cash flow is -$84.4M (FY2025).
Not investment advice. Cached statements, not a live tape.